Henry O. Meissner

571 total citations
31 papers, 443 citations indexed

About

Henry O. Meissner is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Complementary and alternative medicine. According to data from OpenAlex, Henry O. Meissner has authored 31 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Complementary and alternative medicine. Recurrent topics in Henry O. Meissner's work include Genomics, phytochemicals, and oxidative stress (9 papers), Phytochemicals and Antioxidant Activities (7 papers) and Complementary and Alternative Medicine Studies (6 papers). Henry O. Meissner is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (9 papers), Phytochemicals and Antioxidant Activities (7 papers) and Complementary and Alternative Medicine Studies (6 papers). Henry O. Meissner collaborates with scholars based in Australia, Poland and United States. Henry O. Meissner's co-authors include I. Atwater, A Mścisz, Bogdan Kędzia, P.M. Mrozikiewicz, Ewa Piątkowska, Paweł M. Pisulewski, T. Bobkiewicz‐Kozłowska, I. Barchia, Jennifer E. Lutomski and Marek Baraniak and has published in prestigious journals such as International Journal of Molecular Sciences, Diabetologia and Molecules.

In The Last Decade

Henry O. Meissner

29 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry O. Meissner Australia 15 180 96 92 85 81 31 443
Diana Serra Portugal 12 259 1.4× 75 0.8× 42 0.5× 136 1.6× 64 0.8× 15 585
Sara Farnetti Italy 16 150 0.8× 55 0.6× 74 0.8× 81 1.0× 19 0.2× 20 720
Lucas Martins França Brazil 13 110 0.6× 98 1.0× 150 1.6× 65 0.8× 35 0.4× 23 504
Elizabeth I. Opara United Kingdom 13 133 0.7× 119 1.2× 54 0.6× 115 1.4× 54 0.7× 29 593
Motoi Tamura Japan 13 246 1.4× 76 0.8× 109 1.2× 83 1.0× 19 0.2× 58 872
Clairce Luzia Salgueiro‐Pagadigorria Brazil 13 147 0.8× 88 0.9× 98 1.1× 60 0.7× 16 0.2× 26 490
Shoko Nishizono Japan 11 148 0.8× 59 0.6× 65 0.7× 103 1.2× 23 0.3× 25 457
Javier Marhuenda Spain 14 138 0.8× 134 1.4× 40 0.4× 158 1.9× 71 0.9× 28 634
Mohammad Zafar Imam Bangladesh 13 148 0.8× 216 2.3× 57 0.6× 50 0.6× 94 1.2× 28 566
Leslie L. Curry United States 9 98 0.5× 94 1.0× 111 1.2× 59 0.7× 21 0.3× 10 695

Countries citing papers authored by Henry O. Meissner

Since Specialization
Citations

This map shows the geographic impact of Henry O. Meissner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry O. Meissner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry O. Meissner more than expected).

Fields of papers citing papers by Henry O. Meissner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry O. Meissner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry O. Meissner. The network helps show where Henry O. Meissner may publish in the future.

Co-authorship network of co-authors of Henry O. Meissner

This figure shows the co-authorship network connecting the top 25 collaborators of Henry O. Meissner. A scholar is included among the top collaborators of Henry O. Meissner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry O. Meissner. Henry O. Meissner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Minich, Deanna M., et al.. (2024). Not All Maca Is Created Equal: A Review of Colors, Nutrition, Phytochemicals, and Clinical Uses. Nutrients. 16(4). 530–530. 8 indexed citations
3.
Gaweł‐Bęben, Katarzyna, Wirginia Kukuła‐Koch, Anna Wawruszak, et al.. (2024). Lepidium peruvianum as a Source of Compounds with Anticancer and Cosmetic Applications. International Journal of Molecular Sciences. 25(19). 10816–10816.
4.
Płaziński, Wojciech, et al.. (2022). The Distribution of Glucosinolates in Different Phenotypes of Lepidium peruvianum and Their Role as Acetyl- and Butyrylcholinesterase Inhibitors—In Silico and In Vitro Studies. International Journal of Molecular Sciences. 23(9). 4858–4858. 16 indexed citations
5.
Kukuła‐Koch, Wirginia, et al.. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules. 26(19). 6087–6087. 13 indexed citations
6.
Geng, Ping, Jianghao Sun, Pei Chen, et al.. (2020). Characterization of Maca (Lepidium meyenii/Lepidium peruvianum) Using a Mass Spectral Fingerprinting, Metabolomic Analysis, and Genetic Sequencing Approach. Planta Medica. 86(10). 674–685. 12 indexed citations
7.
Harnly, James M., et al.. (2018). Chemical and genetic characterization of Maca (Lepidium meyenii). Planta Medica International Open. 2 indexed citations
8.
Kędzia, Anna, Andrzej Kędzia, Henry O. Meissner, & Joanna Wiśniewska. (2018). Ocena działania olejku majerankowego wobec bakterii beztlenowych. Postępy Fitoterapii. 19(4). 1 indexed citations
9.
Meissner, Henry O., A Mścisz, Marek Baraniak, et al.. (2017). Peruvian Maca (Lepidium peruvianum) - III: The Effects of Cultivation Altitude on Phytochemical and Genetic Differences in the Four Prime Maca Phenotypes. International Journal of Biomedical Science. 13(2). 58–73. 11 indexed citations
10.
Kędzia, Anna, et al.. (2016). EVALUATION OF THE TEA TREE OIL ACTIVITY TO ANAEROBIC BACTERIA--IN VITRO STUDY.. PubMed. 73(2). 389–94. 7 indexed citations
11.
Kędzia, Anna, A Mścisz, & Henry O. Meissner. (2011). The effect of Tamanu oil ( Calophyllum inophyllum ) on anaerobic bacteria isolated from respiratory tract. Postępy Fitoterapii. 1 indexed citations
12.
Meissner, Henry O., et al.. (2006). Short and Long-Term Physiological Responses of Male and Female Rats to Two Dietary levels of Pre-Gelatinized Maca (Lepidium Peruvianum Chacon). International Journal of Biomedical Science. 2(1). 15–29. 9 indexed citations
13.
Meissner, Henry O., P.M. Mrozikiewicz, T. Bobkiewicz‐Kozłowska, et al.. (2006). Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (I) Biochemical and Pharmacodynamic Study on Maca using Clinical Laboratory Model on Ovariectomized Rats.. PubMed. 2(3). 260–72. 12 indexed citations
14.
Meissner, Henry O., et al.. (2006). Therapeutic Effects of Pre-Gelatinized Maca (Lepidium peruvianum Chacon) used as a non-hormonal alternative to HRT in perimenopausal women - Clinical Pilot Study. International Journal of Biomedical Science. 2(2). 143–159. 22 indexed citations
15.
Meissner, Henry O., A Mścisz, P.M. Mrozikiewicz, et al.. (2006). Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (III) Clinical responses of early-postmenopausal women to Maca in double blind, randomized, Placebo-controlled, crossover configuration, outpatient study.. PubMed. 2(4). 375–94. 21 indexed citations
18.
Meissner, Henry O.. (2005). Use of Gelatinized Maca (Lepidium peruvianum) in Early Postmenopausal Women - a Pilot Study. International Journal of Biomedical Science. 1(1). 33–45. 21 indexed citations
19.
Meissner, Henry O., M. Ohshima, & Hiro-omi YOKOTA. (1995). Hypocholesterolemic Activity of a Commercial High-Protein Leaf Extract used as a Natural Source of Pigments for Laying Hens and Growing Chickens.. Japanese poultry science. 32(3). 184–193. 3 indexed citations
20.
Meissner, Henry O. & I. Atwater. (1976). The Kinetics of Electrical Activity of Beta Cells in Response to a "Square Wave" Stimulation with Glucose or Glibenclamide. Hormone and Metabolic Research. 8(1). 11–16. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026